BILIARY CANCERS

Clinical trials for BILIARY CANCERS explained in plain language.

Never miss a new study

Get alerted when new BILIARY CANCERS trials appear

Sign up with your email to follow new studies for BILIARY CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug targets Hard-to-Treat cancers in early trial

Disease control Not yet recruiting

This study tests a new drug called INV-8989 in people with advanced solid tumors that have a specific genetic change called KRAS G12D. The goal is to see if the drug is safe and can shrink tumors. About 178 adults with cancers like pancreatic, lung, or colorectal cancer will take…

Matched conditions: BILIARY CANCERS

Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control

Last updated Jun 05, 2026 12:07 UTC

BILIARY CANCERS

Get alerted when new BILIARY CANCERS trials appear

New drug targets Hard-to-Treat cancers in early trial